BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12446178)

  • 1. Arginase expression and modulation of IL-1beta-induced nitric oxide generation in rat and human islets of Langerhans.
    Stickings P; Mistry SK; Boucher JL; Morris SM; Cunningham JM
    Nitric Oxide; 2002 Dec; 7(4):289-96. PubMed ID: 12446178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1beta-mediated inhibition of arginase in RINm5F cells.
    Cunningham JM; Mabley JG; Green IC
    Cytokine; 1997 Aug; 9(8):570-6. PubMed ID: 9245484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
    Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
    Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation.
    Kim MJ; Ryu GR; Kang JH; Sim SS; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jeong IK; Hong KJ; Kim MS; Jo YH
    Biochem Pharmacol; 2004 Nov; 68(9):1775-85. PubMed ID: 15450943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1beta-induced nitric oxide production and inhibition of insulin secretion in rat islets of langerhans is dependent upon the nitric oxide synthase cofactor tetrahidrobiopterin.
    Stickings P; Cunningham JM
    Cytokine; 2002 Apr; 18(2):81-5. PubMed ID: 12096922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
    Wadt KA; Larsen CM; Andersen HU; Nielsen K; Karlsen AE; Mandrup-Poulsen T
    Diabetes; 1998 Oct; 47(10):1602-8. PubMed ID: 9753298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein induction in islets of Langerhans and insulinoma cells.
    Laychock SG; Duzen J; Simpkins CO
    Mol Cell Endocrinol; 2000 Jul; 165(1-2):179-87. PubMed ID: 10940496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1beta-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases.
    Larsen CM; Wadt KA; Juhl LF; Andersen HU; Karlsen AE; Su MS; Seedorf K; Shapiro L; Dinarello CA; Mandrup-Poulsen T
    J Biol Chem; 1998 Jun; 273(24):15294-300. PubMed ID: 9614146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock inhibits cytokine-induced nitric oxide synthase expression by rat and human islets.
    Scarim AL; Heitmeier MR; Corbett JA
    Endocrinology; 1998 Dec; 139(12):5050-7. PubMed ID: 9832444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
    Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
    Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat pancreatic islet and RINm5F cell responses to epiandrosterone, dehydroepiandrosterone and interleukin-1 beta.
    Laychock SG
    Biochem Pharmacol; 1998 May; 55(9):1453-64. PubMed ID: 10076538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical and slow-binding inhibitors of human type II arginase.
    Colleluori DM; Ash DE
    Biochemistry; 2001 Aug; 40(31):9356-62. PubMed ID: 11478904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo.
    Rydgren T; Sandler S
    Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta 1 prevents cytokine-mediated inhibitory effects and induction of nitric oxide synthase in the RINm5F insulin-containing beta-cell line.
    Mabley JG; Cunningham JM; John N; Di Matteo MA; Green IC
    J Endocrinol; 1997 Dec; 155(3):567-75. PubMed ID: 9488002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1beta regulates phospholipase D-1 expression in rat pancreatic beta-cells.
    Chen MC; Paez-Espinosa V; Welsh N; Eizirik DL
    Endocrinology; 2000 Aug; 141(8):2822-8. PubMed ID: 10919268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells.
    Li H; Meininger CJ; Hawker JR; Haynes TE; Kepka-Lenhart D; Mistry SK; Morris SM; Wu G
    Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E75-82. PubMed ID: 11120661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stimulatory effect of IL-1beta on the insulin secretion of rat pancreatic islet is not related with iNOS pathway.
    Jeong IK; Oh SH; Chung JH; Min YK; Lee MS; Lee MK; Kim KW
    Exp Mol Med; 2002 Mar; 34(1):12-7. PubMed ID: 11989973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cyclooxygenase-2 in cytokine-induced beta-cell dysfunction and damage by isolated rat and human islets.
    Heitmeier MR; Kelly CB; Ensor NJ; Gibson KA; Mullis KG; Corbett JA; Maziasz TJ
    J Biol Chem; 2004 Dec; 279(51):53145-51. PubMed ID: 15471850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase.
    Laychock SG; Modica ME; Cavanaugh CT
    Endocrinology; 1991 Dec; 129(6):3043-52. PubMed ID: 1683279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
    Darville MI; Eizirik DL
    Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.